Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease

Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease

Inflammatory bowel disease (IBD) is a special chronic intestinal inflammatory disease, which is mainly divided into Crohn's disease (CD) and ulcerative colitis (UC). Its occurrence is a complex process that regulated by multiple signaling pathways, including nuclear factor erythroid 2-related f...

Full description

Bibliographic Details
Main Authors:	Botong Li, Yixuan Wang, Xiaolin Jiang, Hongwei Du, Yan Shi, Minghui Xiu, Yongqi Liu, Jianzheng He
Format:	Article
Language:	English
Published:	Elsevier 2023-08-01
Series:	Biomedicine & Pharmacotherapy
Subjects:	Nrf2/ARE signaling pathway Inflammatory bowel disease Nature compounds Natural extract Compound recipe Gut microbe
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332223007400

Similar Items

Using Drosophila melanogaster as a suitable platform for drug discovery from natural products in inflammatory bowel disease
by: Minghui Xiu, et al.
Published: (2022-12-01)

Protective effect of astragalus membranaceus and its bioactive compounds against the intestinal inflammation in Drosophila
by: Jianzheng He, et al.
Published: (2022-12-01)

The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy
by: Shuo Yuan, et al.
Published: (2023-09-01)

Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease
by: Samuel Fernández-Tomé, et al.
Published: (2021-09-01)

Activation of Nrf2 by Natural Bioactive Compounds: A Promising Approach for Stroke?
by: Agnese Gugliandolo, et al.
Published: (2020-07-01)

Prediction of Inflammatory Bowel Disease Course Based on Fecal Scent
by: Sofie Bosch, et al.
Published: (2022-03-01)

Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential
by: Qiuyun Xu, et al.
Published: (2022-08-01)

Resveratrol and its derivates improve inflammatory bowel disease by targeting gut microbiota and inflammatory signaling pathways
by: Ming Li, et al.
Published: (2022-01-01)

Inflammatory Bowel Disease-Associated Gut Commensals Degrade Components of the Extracellular Matrix
by: Ana Maria Porras, et al.
Published: (2022-12-01)

Stool multi-omics for the study of host–microbe interactions in inflammatory bowel disease
by: Consuelo Sauceda, et al.
Published: (2022-12-01)

Anti-inflammatory effect of walnut-derived peptide via the activation of Nrf2/Keap1 pathway against oxidative stress
by: Yuan Qi, et al.
Published: (2023-11-01)

Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored
by: Mengjie Zhu, et al.
Published: (2023-07-01)

Altered gut bacterial and metabolic signatures and their interaction in inflammatory bowel disease
by: Guangcai Liang
Published: (2021-12-01)

Cytotoxic Natural Products from Marine Sponge-Derived Microorganisms
by: Huawei Zhang, et al.
Published: (2017-03-01)

Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets
by: Arno R. Bourgonje, et al.
Published: (2023-04-01)

Integrated annotation prioritizes metabolites with bioactivity in inflammatory bowel disease
by: Amrisha Bhosle, et al.
Published: (2024-03-01)

Interactions between Medications and the Gut Microbiome in Inflammatory Bowel Disease
by: Julia Eckenberger, et al.
Published: (2022-10-01)

An insight into genetic landscape of inflammatory bowel disease
by: Zunaira Ali Baig, et al.
Published: (2023-11-01)

The Potential of Natural Oils to Improve Inflammatory Bowel Disease
by: Yaxi Zhou, et al.
Published: (2023-06-01)

Macrophage polarization in inflammatory bowel disease
by: Kun Zhang, et al.
Published: (2023-12-01)

Coriolus Versicolor Downregulates TLR4/NF-κB Signaling Cascade in Dinitrobenzenesulfonic Acid-Treated Mice: A Possible Mechanism for the Anti-Colitis Effect
by: Daniela Impellizzeri, et al.
Published: (2022-02-01)

What Was First, Obesity or Inflammatory Bowel Disease? What Does the Gut Microbiota Have to Do with It?
by: Sara Jarmakiewicz-Czaja, et al.
Published: (2020-10-01)

The Role of Gut Microbiome in Initiation of Inflammatory Bowel Disease; A Review
by: Taher Azimi, et al.
Published: (2020-04-01)

In Silico Approach to Assessing the Polyphenols from Krishna Tulsi (<i>Ocimum tenuiflorum</i> L.) as a Keap1/Nrf2 Receptor for the Treatment of Inflammatory Bowel Disease
by: Satish Kumar, et al.
Published: (2023-03-01)

The Antioxidant and Anti-Inflammatory Effects of Flavonoids from Propolis via Nrf2 and NF-κB Pathways
by: Wenzhen Xu, et al.
Published: (2022-08-01)

A Combination of Xyloglucan, Pea Protein and Chia Seed Ameliorates Intestinal Barrier Integrity and Mucosa Functionality in a Rat Model of Constipation-Predominant Irritable Bowel Syndrome
by: Alessia Filippone, et al.
Published: (2022-11-01)

Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
by: Pablo Angulo, et al.
Published: (2017-01-01)

Food Additives Associated with Gut Microbiota Alterations in Inflammatory Bowel Disease: Friends or Enemies?
by: Caiguang Liu, et al.
Published: (2022-07-01)

Assessing the effect of interaction between gut microbiome and inflammatory bowel disease on the risks of depression
by: Xiaoyue Qin, et al.
Published: (2022-12-01)

Health Benefits of Dietary Fiber for the Management of Inflammatory Bowel Disease
by: Kafayat Yusuf, et al.
Published: (2022-05-01)

Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease
by: Colin F. Craig, et al.
Published: (2022-01-01)

Anti-Aging Effect of Dietary Fiber Compound Mediated by Guangxi Longevity Dietary Pattern on Natural Aging Mice
by: Xiaohan Yu, et al.
Published: (2022-08-01)

Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments
by: Yaxi Zhou, et al.
Published: (2023-02-01)

An evaluation of animal models for using bioactive compounds in the treatment of inflammatory bowel disease
by: Shanshan Tie, et al.
Published: (2024-03-01)

Chitosan-insulin nano-formulations as critical modulators of inflammatory cytokines and Nrf-2 pathway to accelerate burn wound healing
by: Deepinder Sharda, et al.
Published: (2023-12-01)

Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets
by: Patricia Teixeira Santana, et al.
Published: (2022-03-01)

Modulation of Nrf2 and NF-κB Signaling Pathways by Naturally Occurring Compounds in Relation to Cancer Prevention and Therapy. Are Combinations Better Than Single Compounds?
by: Violetta Krajka-Kuźniak, et al.
Published: (2021-07-01)

The intestinal microbiome of inflammatory bowel disease across the pediatric age range
by: Máire A. Conrad, et al.
Published: (2024-12-01)

Natural Products as Modulators of Nrf2 Signaling Pathway in Neuroprotection
by: Ignacio Moratilla-Rivera, et al.
Published: (2023-02-01)

Modulation of NRF2/KEAP1-Mediated Oxidative Stress for Cancer Treatment by Natural Products Using Pharmacophore-Based Screening, Molecular Docking, and Molecular Dynamics Studies
by: Abdulrahim A. Alzain, et al.
Published: (2023-08-01)